$4.7B Express Scripts-NextRX Merger Accelerates

Law360, New York (May 28, 2009, 12:00 AM EDT) -- Express Scripts Inc. announced Thursday that its planned $4.68 billion acquisition of pharmacy benefits manager NextRX LLC was moving ahead full steam after a mandatory antitrust review period came to an end with no action taken by regulators.

St. Louis-based Express Scripts said the waiting period required under the Hart-Scott-Rodino Act in connection with its premerger notification filing relating to its proposed acquisition of NextRx — a subsidiary of health insurer WellPoint Inc. — expired on Wednesday, representing a “significant step forward” toward completion of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.